Shearman & Sterling advised BofA Securities as the sole book-running manager of Axonics’s follow-on public offering of 2,012,500 shares of common stock at a price of $63.85 per share to BofA Securities, resulting in gross proceeds to the Company of approximately $128.5 million. The offering included 262,500 shares sold pursuant to the exercise in full of the option to purchase additional shares granted to BofA Securities by Axonics in connection with the offering.

Axonics, based in Irvine, California, is a global medical technology company that is developing and commercializing novel products for adults with bladder and bowel dysfunction.

The Team